Stockchase Opinions

Jim Cramer - Mad Money Catalent CTLT-N DON'T BUY Mar 22, 2023

Danaher (he owns) or Illumina could buy CTLT, at least that's the talk. Until something happens, he won't buy this.

N/A

Stock price when the opinion was issued

biotechnology pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

BUY

They make the tools that helped Moderna make the Covid vaccine. Roared during the pandemic, then crashed in 2022, but is soaring now. Rumoured that Danaher could take this over.

DON'T BUY

They had a financial problem. Stay away for a while.